Lexeo Therapeutics vs MacroGenics
Lexeo Therapeutics vs MacroGenics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Lexeo Therapeutics is on 61/100 and MacroGenics on 49/100.
Where each one leads
Lexeo Therapeutics
- our overall score: 61/100 against 49/100
- agent readiness: 40/100 against 35/100
- funding raised: $495M against $13.5M
MacroGenics
- domain rating: 50/100 against 41/100
At a glance
| Measure | Lexeo Therapeutics | MacroGenics |
|---|---|---|
| What it is | Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. | Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2020 | 2000 |
| Headquarters | New York City, United States | Rockville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Lexeo Therapeutics | MacroGenics |
|---|---|---|
| Employees | 91 | Not published |
| Total funding | $495M | $13.5M |
| Latest round | Public Offering | Series A |
| LinkedIn followers | 16,654 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Lexeo Therapeutics | MacroGenics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 49/100 |
| Traction | 60/100 | 36/100 |
| Team | 70/100 | 70/100 |
| Community | 8/100 | Not published |
| Search visibility | 28/100 | 12/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 41/100 | 50/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Lexeo Therapeutics | MacroGenics |
|---|---|---|
| Hosting | Self Managed | Google Cloud |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
Lexeo Therapeutics vs MacroGenics: common questions
Which is better, Lexeo Therapeutics or MacroGenics?
On our 0-100 score Lexeo Therapeutics rates higher (61/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Lexeo Therapeutics and MacroGenics compare on the numbers?
Lexeo Therapeutics leads on our overall score (61/100 against 49/100), agent readiness (40/100 against 35/100), funding raised ($495M against $13.5M). MacroGenics leads on domain rating (50/100 against 41/100).
Read the full Lexeo Therapeutics review and pricing or the MacroGenics review and pricing. You can also browse other Lexeo Therapeutics alternatives we track.